How should a research site prepare for a monitoring visit?
Prepare for a monitoring visit by working the open items from the last visit, bringing source records and data entry up to date, and checking the consent forms, safety reports, product records and site file the monitor will review (ICH E6(R3) 3.11.4.5.2).
Then agree an agenda, book the investigator's time and arrange record access.
What the monitor is there to check
ICH E6(R3) lists the monitoring activities. Among them, the monitor confirms that staff are informed and follow the current protocol, that the investigator is maintaining the essential records, that consent was obtained before participation, and that adverse events are reported within the required time periods (ICH E6(R3) 3.11.4.5.2(b)).
The monitor also informs the investigator of relevant deviations and of entry errors or omissions, so that corrections are made, dated and explained where needed (ICH E6(R3) 3.11.4.5.1(c)).
One to two weeks before
- Read the last follow-up letter and close or update every open item.
- Enter all visit data and answer open queries.
- Check every consent form for the right version, signatures and dates, and that the consent process is documented in the source.
- Reconcile serious adverse events in the source with what was sent to the sponsor.
- Update product accountability and temperature logs.
- File new documents in the investigator site file and check the delegation record and training records are current.
On the day
- Give the monitor a quiet space and the access agreed in advance, including remote or read-only access to electronic records where used (ICH E6(R3) 3.11.4.1).
- Keep the coordinator available for questions and book time with the investigator to discuss findings.
- Write down every question the monitor raises, so nothing depends on memory.
After the visit
The follow-up letter is the site's to-do list. Assign each item an owner and a date, fix the root cause of repeated findings rather than only the single record, and document important deviations and the measures taken to prevent a recurrence (ICH E6(R3) 2.5.3). Keep the letter and your responses in the site file.
Questions people also ask
How often do monitoring visits happen?
There is no fixed frequency. ICH E6(R3) says on-site and remote monitoring are planned in proportion to the trial's risks (ICH E6(R3) 3.11.4.1), so the sponsor's monitoring plan sets it for each study.
Can a monitor review records remotely?
Yes, where the sponsor's plan and local rules allow it, including read-only remote access to source records (ICH E6(R3) 3.11.4.1).
Does the investigator have to meet the monitor?
The investigator keeps responsibility for the trial at the site and should be available to discuss important findings; the monitor communicates deviations to the investigator (ICH E6(R3) 3.11.4.5.1(b)).
What is the difference between a monitoring visit and an audit?
Monitoring is ongoing quality control by the sponsor's monitor; an audit is an independent check of whether the trial and its systems met the protocol, GCP and the regulations (ICH E6(R3) 3.11.2).
Primary sources
- ICH E6(R3) Guideline for Good Clinical Practice, final version adopted 6 January 2025 (ICH): https://database.ich.org/sites/default/files/ICH_E6%28R3%29_Step4_FinalGuideline_2025_0106.pdf
- Oversight of Clinical Investigations: A Risk-Based Approach to Monitoring, guidance (FDA): https://www.fda.gov/regulatory-information/search-fda-guidance-documents/oversight-clinical-investigations-risk-based-approach-monitoring
- E6(R3) Good Clinical Practice, final guidance (U.S. Food and Drug Administration): https://www.fda.gov/regulatory-information/search-fda-guidance-documents/e6r3-good-clinical-practice-gcp
Last reviewed
2026-11-14